Information Library

Results for: Clinical and marketing materials - Clinical Services - Europe

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Energizing Enrollment

    Case Study — October 4, 2011
    The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned.

  • Model-Based Drug Development

    Brochure — October 4, 2011
    Our industry-leading model-based drug development services boost the probability of success in the New Health by enabling you to make critical decisions earlier, optimizing your resources and returns.

  • Polish Pharmaceutical and Healthcare Sector

    Media Coverage — September 9, 2011
    To say ‘Sleeping Giant’ about Poland is no longer true claims Wojciech Przybys, VP EMEA and provides a deeper analysis of the polish clinical research

  • Genomics Fact Sheet

    Brochure — June 17, 2011
    Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area.

  • Superior Teamwork - Renal Transplants

    Case Study — February 2, 2011
    901 patients were randomized according to the protocol timelines. The database lock was achieved 11 days before the original target date.

  • Bypassing Barriers - Refractory Partial Epilepsy

    Case Study — February 2, 2011
    Despite a difficult and limited patient population, Quintiles randomized 388 patients (13 over target) 10 weeks ahead of schedule.

  • Diabetes - Therapeutic Focus

    Case Study — February 1, 2011
    A dose-ranging clinical study to evaluate the safety, efficacy and tolerability of five doses of Drug X compared with placebo in Type II diabetes patients with no prior exposure to anti-diabetic medication.

  • Parkinson's Disease - Ambitious Recruitment

    Case Study — February 1, 2011
    Quintiles provided project management, clinical monitoring, and more for a study of a drug for patients with early stage idiopathic Parkinson’s disease.

  • Epilepsy - Refining Recruitment

    Case Study — February 1, 2011
    Quintiles provided clinical monitoring and project management for a randomized, double-blind, parallel-group, placebo and comparator controlled multicenter study of Drug X in patients with epilepsy.

  • Global Response HIV

    Case Study — February 1, 2011
    Due to its global reach and extensive experience, Quintiles successfully managed 830 sites in 32 countries and recruited 14,521 patients.

Page 1 of 2 (13 results)

Subscribe to Email Based on Your Interests

Set preferences